Latest Insider Transactions at Inari Medical, Inc. (NARI)
This section provides a real-time view of insider transactions for Inari Medical, Inc. (NARI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Inari Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Inari Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 06
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.92%
|
$0
$0.43 P/Share
|
|
May 27
2022
|
Donald B Milder Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,983
+1.18%
|
-
|
|
May 27
2022
|
Jonathan D Root Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,983
+0.56%
|
-
|
|
May 27
2022
|
Kirk G. Nielsen Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,983
+5.05%
|
-
|
|
May 26
2022
|
Donald B Milder Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+0.97%
|
-
|
|
May 26
2022
|
Jonathan D Root Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+0.46%
|
-
|
|
May 26
2022
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+7.05%
|
-
|
|
May 26
2022
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+30.13%
|
-
|
|
May 26
2022
|
Kirk G. Nielsen Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+4.36%
|
-
|
|
May 26
2022
|
Dana G Mead Jr. Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+34.42%
|
-
|
|
May 26
2022
|
Cynthia L Lucchese Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+7.05%
|
-
|
|
May 26
2022
|
Rebecca Chambers Director |
BUY
Grant, award, or other acquisition
|
Direct |
2,420
+35.64%
|
-
|
|
May 16
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-1.78%
|
$442,500
$59.05 P/Share
|
|
May 16
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.93%
|
$0
$0.46 P/Share
|
|
May 10
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+21.77%
|
$0
$0.46 P/Share
|
|
May 05
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-0.28%
|
$2,250,000
$75.22 P/Share
|
|
May 05
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+2.52%
|
$0
$0.43 P/Share
|
|
May 02
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
5,000
-0.64%
|
$395,000
$79.65 P/Share
|
|
Apr 18
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.22%
|
$652,500
$87.8 P/Share
|
|
Apr 18
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.93%
|
$0
$0.46 P/Share
|
|
Apr 18
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
7,000
-0.05%
|
$609,000
$87.83 P/Share
|
|
Apr 05
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
30,000
-1.75%
|
$2,670,000
$89.73 P/Share
|
|
Apr 05
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+4.92%
|
$0
$0.43 P/Share
|
|
Apr 01
2022
|
William Hoffman Director |
SELL
Payment of exercise price or tax liability
|
Direct |
1,540
-0.14%
|
$138,600
$90.92 P/Share
|
|
Apr 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
10,000
-1.23%
|
$910,000
$91.22 P/Share
|
|
Apr 01
2022
|
Andrew Hykes President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
993
-0.3%
|
$89,370
$90.92 P/Share
|
|
Apr 01
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
662
-0.41%
|
$59,580
$90.92 P/Share
|
|
Apr 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
680
-0.43%
|
$61,200
$90.92 P/Share
|
|
Mar 28
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2,000
-2.48%
|
$180,000
$90.0 P/Share
|
|
Mar 28
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+2.43%
|
$0
$0.46 P/Share
|
|
Mar 16
2022
|
Andrew Hykes President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.62%
|
$0
$0.43 P/Share
|
|
Mar 16
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Direct |
7,000
-2.87%
|
$560,000
$80.18 P/Share
|
|
Mar 15
2022
|
Hill, Mitch C. Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
7,500
-2.68%
|
$562,500
$75.94 P/Share
|
|
Mar 15
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+7.3%
|
$0
$0.46 P/Share
|
|
Mar 07
2022
|
William Hoffman Director |
SELL
Open market or private sale
|
Direct |
60,000
-0.79%
|
$5,760,000
$96.42 P/Share
|
|
Mar 07
2022
|
William Hoffman Director |
BUY
Exercise of conversion of derivative security
|
Direct |
30,000
+5.01%
|
$0
$0.43 P/Share
|
|
Mar 03
2022
|
Donald B Milder Director |
SELL
Bona fide gift
|
Indirect |
210,000
-5.41%
|
-
|
|
Mar 01
2022
|
Robert Keith Warner Director |
BUY
Grant, award, or other acquisition
|
Direct |
3,191
+50.0%
|
-
|
|
Mar 01
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
13,696
-1.03%
|
$1,232,640
$90.74 P/Share
|
|
Mar 01
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
2
-0.0%
|
$180
$90.0 P/Share
|
|
Mar 01
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
2
+0.0%
|
$0
$0.46 P/Share
|
|
Feb 28
2022
|
Andrew Hykes President and CEO |
SELL
Open market or private sale
|
Direct |
6,304
-1.79%
|
$567,360
$90.05 P/Share
|
|
Feb 28
2022
|
Thomas Tu Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
3,998
-2.46%
|
$359,820
$90.01 P/Share
|
|
Feb 28
2022
|
Thomas Tu Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,998
+4.63%
|
$0
$0.46 P/Share
|
|
Feb 24
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
4,172
-0.05%
|
$333,760
$80.06 P/Share
|
|
Feb 23
2022
|
Donald B Milder Director |
SELL
Open market or private sale
|
Indirect |
100
-0.0%
|
$8,000
$80.0 P/Share
|
|
Feb 17
2022
|
Thomas Tu Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,936
+20.3%
|
-
|
|
Feb 17
2022
|
Hill, Mitch C. Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,936
+18.52%
|
-
|
|
Feb 17
2022
|
Andrew Hykes President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
29,879
+14.37%
|
-
|
|
Feb 17
2022
|
William Hoffman Director |
BUY
Grant, award, or other acquisition
|
Direct |
43,708
+6.98%
|
-
|